메뉴 건너뛰기




Volumn 82, Issue 2, 2013, Pages 340-345

Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study

Author keywords

Chemotherapy; MicroRNA; Non small cell lung carcinoma; Prognosis; Response prediction; Survival

Indexed keywords

CISPLATIN; MICRORNA; MICRORNA 124; MICRORNA 149; MICRORNA 200C; MICRORNA 29C; MICRORNA 375; MICRORNA 424; NAVELBINE; UNCLASSIFIED DRUG;

EID: 84887021692     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2013.07.020     Document Type: Article
Times cited : (52)

References (49)
  • 1
    • 34548457234 scopus 로고    scopus 로고
    • The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours
    • Goldstraw P., Crowley J., Chansky K., Giroux D.J., Groome P.A., Rami-Porta R., et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007, 2(August (8)):706-714.
    • (2007) J Thorac Oncol , vol.2 , Issue.8 AUGUST , pp. 706-714
    • Goldstraw, P.1    Crowley, J.2    Chansky, K.3    Giroux, D.J.4    Groome, P.A.5    Rami-Porta, R.6
  • 2
    • 50849092122 scopus 로고    scopus 로고
    • European Lung Cancer Working Party Clinical Practice Guidelines: clinical practice guidelines, non-small cell lung cancer: III. Metastatic disease
    • Alexopoulos A., Alard S., Berghmans T., Berchier M.C., Bonduelle Y., Colinet, et al. European Lung Cancer Working Party Clinical Practice Guidelines: clinical practice guidelines, non-small cell lung cancer: III. Metastatic disease. Hospital Chronicles 2008, 1(3):169-185.
    • (2008) Hospital Chronicles , vol.1 , Issue.3 , pp. 169-185
    • Alexopoulos, A.1    Alard, S.2    Berghmans, T.3    Berchier, M.C.4    Bonduelle, Y.5    Colinet, B.6
  • 3
    • 0030276781 scopus 로고    scopus 로고
    • The Ontario cancer treatment practice guidelines initiative
    • NOVEMBER (11 Suppl.)
    • Levine M., Browman G., Newman T., Cowan D.H. The Ontario cancer treatment practice guidelines initiative. Oncology (Williston Park) 1996, 10(November (11 Suppl.)):19-22.
    • (1996) Oncology (Williston Park) , vol.10 , pp. 19-22
    • Levine, M.1    Browman, G.2    Newman, T.3    Cowan, D.H.4
  • 4
    • 1342268525 scopus 로고    scopus 로고
    • American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003
    • Pfister D.G., Johnson D.H., Azzoli C.G., Sause W., Smith T.J., Baker S., et al. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol 2004, 22(January (2)):330-353.
    • (2004) J Clin Oncol , vol.22 , Issue.2 JANUARY , pp. 330-353
    • Pfister, D.G.1    Johnson, D.H.2    Azzoli, C.G.3    Sause, W.4    Smith, T.J.5    Baker, S.6
  • 5
    • 34848849863 scopus 로고    scopus 로고
    • Treatment of non-small cell lung cancer, stage IV: ACCP evidence-based clinical practice guidelines (2nd edition)
    • September (3 Suppl.)
    • Socinski M.A., Crowell R., Hensing T.E., Langer C.J., Lilenbaum R., Sandler A.B., et al. Treatment of non-small cell lung cancer, stage IV: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007, 132(September (3 Suppl.)):277S-289S.
    • (2007) Chest , vol.132
    • Socinski, M.A.1    Crowell, R.2    Hensing, T.E.3    Langer, C.J.4    Lilenbaum, R.5    Sandler, A.B.6
  • 6
    • 84862302379 scopus 로고    scopus 로고
    • Non-platinum regimens of gemcitabine plus docetaxel versus platinum-based regimens in first-line treatment of advanced non-small cell lung cancer: a meta-analysis on 9 randomized controlled trials
    • Yu Y., Xu X., Du Z., Shi M. Non-platinum regimens of gemcitabine plus docetaxel versus platinum-based regimens in first-line treatment of advanced non-small cell lung cancer: a meta-analysis on 9 randomized controlled trials. Cancer Chemother Pharmacol 2012, 69(May (5)):1265-1275.
    • (2012) Cancer Chemother Pharmacol , vol.69 , Issue.5 MAY , pp. 1265-1275
    • Yu, Y.1    Xu, X.2    Du, Z.3    Shi, M.4
  • 7
    • 84857414572 scopus 로고    scopus 로고
    • Efficacy of EGFR tyrosine kinase inhibitors in patients with EGFR-mutated non-small-cell lung cancer: a meta-analysis of 13 randomized trials
    • Petrelli F., Borgonovo K., Cabiddu M., Barni S. Efficacy of EGFR tyrosine kinase inhibitors in patients with EGFR-mutated non-small-cell lung cancer: a meta-analysis of 13 randomized trials. Clin Lung Cancer 2012, 13(March (2)):107-114.
    • (2012) Clin Lung Cancer , vol.13 , Issue.2 MARCH , pp. 107-114
    • Petrelli, F.1    Borgonovo, K.2    Cabiddu, M.3    Barni, S.4
  • 8
    • 84866934606 scopus 로고    scopus 로고
    • Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study
    • Camidge D.R., Bang Y.J., Kwak E.L., Iafrate A.J., Varella-Garcia M., Fox S.B., et al. Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study. Lancet Oncol 2012, 13(October (10)):1011-1019.
    • (2012) Lancet Oncol , vol.13 , Issue.10 OCTOBER , pp. 1011-1019
    • Camidge, D.R.1    Bang, Y.J.2    Kwak, E.L.3    Iafrate, A.J.4    Varella-Garcia, M.5    Fox, S.B.6
  • 9
    • 84864280988 scopus 로고    scopus 로고
    • ERCC1 expression as a prognostic and predictive factor in patients with non-small cell lung cancer: a meta-analysis
    • Jiang J., Liang X., Zhou X., Huang R., Chu Z., Zhan Q. ERCC1 expression as a prognostic and predictive factor in patients with non-small cell lung cancer: a meta-analysis. Mol Biol Rep 2012, 39(June (6)):6933-6942.
    • (2012) Mol Biol Rep , vol.39 , Issue.6 JUNE , pp. 6933-6942
    • Jiang, J.1    Liang, X.2    Zhou, X.3    Huang, R.4    Chu, Z.5    Zhan, Q.6
  • 10
    • 84856576940 scopus 로고    scopus 로고
    • RRM1 expression and clinical outcome of gemcitabine-containing chemotherapy for advanced non-small-cell lung cancer: a meta-analysis
    • Gong W., Zhang X., Wu J., Chen L., Li L., Sun J., et al. RRM1 expression and clinical outcome of gemcitabine-containing chemotherapy for advanced non-small-cell lung cancer: a meta-analysis. Lung Cancer 2012, 75(March (3)):374-380.
    • (2012) Lung Cancer , vol.75 , Issue.3 MARCH , pp. 374-380
    • Gong, W.1    Zhang, X.2    Wu, J.3    Chen, L.4    Li, L.5    Sun, J.6
  • 11
    • 34447573875 scopus 로고    scopus 로고
    • Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: a phase III trial in non-small-cell lung cancer
    • Cobo M., Isla D., Massuti B., Montes A., Sanchez J.M., Provencio M., et al. Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: a phase III trial in non-small-cell lung cancer. J Clin Oncol 2007, 25(July (19)):2747-2754.
    • (2007) J Clin Oncol , vol.25 , Issue.19 JULY , pp. 2747-2754
    • Cobo, M.1    Isla, D.2    Massuti, B.3    Montes, A.4    Sanchez, J.M.5    Provencio, M.6
  • 12
    • 79952539094 scopus 로고    scopus 로고
    • Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549)
    • Bian H.B., Pan X., Yang J.S., Wang Z.X., De W. Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549). J Exp Clin Cancer Res 2011, 30:20.
    • (2011) J Exp Clin Cancer Res , vol.30 , pp. 20
    • Bian, H.B.1    Pan, X.2    Yang, J.S.3    Wang, Z.X.4    De, W.5
  • 13
    • 77957280345 scopus 로고    scopus 로고
    • Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer
    • Ceppi P., Mudduluru G., Kumarswamy R., Rapa I., Scagliotti G.V., Papotti M., et al. Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer. Mol Cancer Res 2010, 8(September (9)):1207-1216.
    • (2010) Mol Cancer Res , vol.8 , Issue.9 SEPTEMBER , pp. 1207-1216
    • Ceppi, P.1    Mudduluru, G.2    Kumarswamy, R.3    Rapa, I.4    Scagliotti, G.V.5    Papotti, M.6
  • 15
    • 77950203807 scopus 로고    scopus 로고
    • MiR-181a and miR-630 regulate cisplatin-induced cancer cell death
    • Galluzzi L., Morselli E., Vitale I., Kepp O., Senovilla L., Criollo A., et al. miR-181a and miR-630 regulate cisplatin-induced cancer cell death. Cancer Res 2010, 70(March (5)):1793-1803.
    • (2010) Cancer Res , vol.70 , Issue.5 MARCH , pp. 1793-1803
    • Galluzzi, L.1    Morselli, E.2    Vitale, I.3    Kepp, O.4    Senovilla, L.5    Criollo, A.6
  • 16
    • 80051761550 scopus 로고    scopus 로고
    • Alterations of microRNAs in cisplatin-resistant human non-small cell lung cancer cells (A549/DDP)
    • Wang Q., Zhong M., Liu W., Li J., Huang J., Zheng L. Alterations of microRNAs in cisplatin-resistant human non-small cell lung cancer cells (A549/DDP). Exp Lung Res 2011, 37(September (7)):427-434.
    • (2011) Exp Lung Res , vol.37 , Issue.7 SEPTEMBER , pp. 427-434
    • Wang, Q.1    Zhong, M.2    Liu, W.3    Li, J.4    Huang, J.5    Zheng, L.6
  • 17
    • 80052660944 scopus 로고    scopus 로고
    • MiR-98 regulates cisplatin-induced A549 cell death by inhibiting TP53 pathway
    • Zhang S., Zhang C., Li Y., Wang P., Yue Z., Xie S. miR-98 regulates cisplatin-induced A549 cell death by inhibiting TP53 pathway. Biomed Pharmacother 2011, 65(September (6)):436-442.
    • (2011) Biomed Pharmacother , vol.65 , Issue.6 SEPTEMBER , pp. 436-442
    • Zhang, S.1    Zhang, C.2    Li, Y.3    Wang, P.4    Yue, Z.5    Xie, S.6
  • 18
    • 77955619456 scopus 로고    scopus 로고
    • MiR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines
    • Zhu W., Shan X., Wang T., Shu Y., Liu P. miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines. Int J Cancer 2010, 127(December (11)):2520-2529.
    • (2010) Int J Cancer , vol.127 , Issue.11 DECEMBER , pp. 2520-2529
    • Zhu, W.1    Shan, X.2    Wang, T.3    Shu, Y.4    Liu, P.5
  • 19
    • 77955093873 scopus 로고    scopus 로고
    • MicroRNA 92a-2*: a biomarker predictive for chemoresistance and prognostic for survival in patients with small cell lung cancer
    • Ranade A.R., Cherba D., Sridhar S., Richardson P., Webb C., Paripati A., et al. MicroRNA 92a-2*: a biomarker predictive for chemoresistance and prognostic for survival in patients with small cell lung cancer. J Thorac Oncol 2010, 5(August (8)):1273-1278.
    • (2010) J Thorac Oncol , vol.5 , Issue.8 AUGUST , pp. 1273-1278
    • Ranade, A.R.1    Cherba, D.2    Sridhar, S.3    Richardson, P.4    Webb, C.5    Paripati, A.6
  • 20
    • 84887017002 scopus 로고    scopus 로고
    • WHO handbook for reporting results of cancer treatment. WHO offset publication n°48, Geneva; 1979.
    • WHO handbook for reporting results of cancer treatment. WHO offset publication n°48, Geneva; 1979.
  • 21
    • 0025066941 scopus 로고
    • More powerful procedures for multiple significance testing
    • Hochberg Y., Benjamini Y. More powerful procedures for multiple significance testing. Stat Med 1990, 9(July (7)):811-818.
    • (1990) Stat Med , vol.9 , Issue.7 JULY , pp. 811-818
    • Hochberg, Y.1    Benjamini, Y.2
  • 22
    • 79959954361 scopus 로고    scopus 로고
    • Independent and tissue-specific prognostic impact of miR-126 in nonsmall cell lung cancer: coexpression with vascular endothelial growth factor-A predicts poor survival
    • Donnem T., Lonvik K., Eklo K., Berg T., Sorbye S.W., Al-Shibli K., et al. Independent and tissue-specific prognostic impact of miR-126 in nonsmall cell lung cancer: coexpression with vascular endothelial growth factor-A predicts poor survival. Cancer 2011, 117(July (14)):3193-3200.
    • (2011) Cancer , vol.117 , Issue.14 JULY , pp. 3193-3200
    • Donnem, T.1    Lonvik, K.2    Eklo, K.3    Berg, T.4    Sorbye, S.W.5    Al-Shibli, K.6
  • 23
    • 78650976540 scopus 로고    scopus 로고
    • Prognostic impact of MiR-155 in non-small cell lung cancer evaluated by in situ hybridization
    • Donnem T., Eklo K., Berg T., Sorbye S.W., Lonvik K., Al-Saad S., et al. Prognostic impact of MiR-155 in non-small cell lung cancer evaluated by in situ hybridization. J Transl Med 2011, 9:6.
    • (2011) J Transl Med , vol.9 , pp. 6
    • Donnem, T.1    Eklo, K.2    Berg, T.3    Sorbye, S.W.4    Lonvik, K.5    Al-Saad, S.6
  • 24
    • 77950498821 scopus 로고    scopus 로고
    • Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer
    • Hu Z., Chen X., Zhao Y., Tian T., Jin G., Shu Y., et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 2010, 28(April (10)):1721-1726.
    • (2010) J Clin Oncol , vol.28 , Issue.10 APRIL , pp. 1721-1726
    • Hu, Z.1    Chen, X.2    Zhao, Y.3    Tian, T.4    Jin, G.5    Shu, Y.6
  • 25
    • 74549121893 scopus 로고    scopus 로고
    • MicroRNA expression differentiates histology and predicts survival of lung cancer
    • Landi M.T., Zhao Y., Rotunno M., Koshiol J., Liu H., Bergen A.W., et al. MicroRNA expression differentiates histology and predicts survival of lung cancer. Clin Cancer Res 2010, 16(January (2)):430-441.
    • (2010) Clin Cancer Res , vol.16 , Issue.2 JANUARY , pp. 430-441
    • Landi, M.T.1    Zhao, Y.2    Rotunno, M.3    Koshiol, J.4    Liu, H.5    Bergen, A.W.6
  • 26
    • 54049115558 scopus 로고    scopus 로고
    • Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR
    • Markou A., Tsaroucha E.G., Kaklamanis L., Fotinou M., Georgoulias V., Lianidou E.S. Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. Clin Chem 2008, 54(October (10)):1696-1704.
    • (2008) Clin Chem , vol.54 , Issue.10 OCTOBER , pp. 1696-1704
    • Markou, A.1    Tsaroucha, E.G.2    Kaklamanis, L.3    Fotinou, M.4    Georgoulias, V.5    Lianidou, E.S.6
  • 27
    • 67651002796 scopus 로고    scopus 로고
    • MicroRNA classifiers for predicting prognosis of squamous cell lung cancer
    • Raponi M., Dossey L., Jatkoe T., Wu X., Chen G., Fan H., et al. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res 2009, 69(July (14)):5776-5783.
    • (2009) Cancer Res , vol.69 , Issue.14 JULY , pp. 5776-5783
    • Raponi, M.1    Dossey, L.2    Jatkoe, T.3    Wu, X.4    Chen, G.5    Fan, H.6
  • 28
    • 79953327117 scopus 로고    scopus 로고
    • The association of microRNA expression with prognosis and progression in early-stage, non-small cell lung adenocarcinoma: a retrospective analysis of three cohorts
    • Saito M., Schetter A.J., Mollerup S., Kohno T., Skaug V., Bowman E.D., et al. The association of microRNA expression with prognosis and progression in early-stage, non-small cell lung adenocarcinoma: a retrospective analysis of three cohorts. Clin Cancer Res 2011, 17(April (7)):1875-1882.
    • (2011) Clin Cancer Res , vol.17 , Issue.7 APRIL , pp. 1875-1882
    • Saito, M.1    Schetter, A.J.2    Mollerup, S.3    Kohno, T.4    Skaug, V.5    Bowman, E.D.6
  • 29
    • 80455173422 scopus 로고    scopus 로고
    • A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis
    • Tan X., Qin W., Zhang L., Hang J., Li B., Zhang C., et al. A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis. Clin Cancer Res 2011, 17(November (21)):6802-6811.
    • (2011) Clin Cancer Res , vol.17 , Issue.21 NOVEMBER , pp. 6802-6811
    • Tan, X.1    Qin, W.2    Zhang, L.3    Hang, J.4    Li, B.5    Zhang, C.6
  • 30
    • 37349096992 scopus 로고    scopus 로고
    • MicroRNA signature predicts survival and relapse in lung cancer
    • Yu S.L., Chen H.Y., Chang G.C., Chen C.Y., Chen H.W., Singh S., et al. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 2008, 13(January (1)):48-57.
    • (2008) Cancer Cell , vol.13 , Issue.1 JANUARY , pp. 48-57
    • Yu, S.L.1    Chen, H.Y.2    Chang, G.C.3    Chen, C.Y.4    Chen, H.W.5    Singh, S.6
  • 31
    • 33644819964 scopus 로고    scopus 로고
    • Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
    • Yanaihara N., Caplen N., Bowman E., Seike M., Kumamoto K., Yi M., et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006, 9(March (3)):189-198.
    • (2006) Cancer Cell , vol.9 , Issue.3 MARCH , pp. 189-198
    • Yanaihara, N.1    Caplen, N.2    Bowman, E.3    Seike, M.4    Kumamoto, K.5    Yi, M.6
  • 32
    • 80053139025 scopus 로고    scopus 로고
    • MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma
    • Jin L., Hu W.L., Jiang C.C., Wang J.X., Han C.C., Chu P., et al. MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma. Proc Natl Acad Sci U S A 2011, 108(September (38)):15840-15845.
    • (2011) Proc Natl Acad Sci U S A , vol.108 , Issue.38 SEPTEMBER , pp. 15840-15845
    • Jin, L.1    Hu, W.L.2    Jiang, C.C.3    Wang, J.X.4    Han, C.C.5    Chu, P.6
  • 33
    • 80052102980 scopus 로고    scopus 로고
    • MiR-149 promotes epithelial-mesenchymal transition and invasion in nasopharyngeal carcinoma cells
    • Luo Z., Zhang L., Li Z., Jiang C., Dai Y., Liu X., et al. miR-149 promotes epithelial-mesenchymal transition and invasion in nasopharyngeal carcinoma cells. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2011, 36(July (7)):604-609.
    • (2011) Zhong Nan Da Xue Xue Bao Yi Xue Ban , vol.36 , Issue.7 JULY , pp. 604-609
    • Luo, Z.1    Zhang, L.2    Li, Z.3    Jiang, C.4    Dai, Y.5    Liu, X.6
  • 34
    • 80053347466 scopus 로고    scopus 로고
    • MiR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer
    • Nishikawa E., Osada H., Okazaki Y., Arima C., Tomida S., Tatematsu Y., et al. miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer. Cancer Res 2011, 71(October (19)):6165-6173.
    • (2011) Cancer Res , vol.71 , Issue.19 OCTOBER , pp. 6165-6173
    • Nishikawa, E.1    Osada, H.2    Okazaki, Y.3    Arima, C.4    Tomida, S.5    Tatematsu, Y.6
  • 35
    • 84863075009 scopus 로고    scopus 로고
    • MiR-375 is highly expressed and possibly transactivated by achaete-scute complex homolog 1 in small-cell lung cancer cells
    • Zhao H., Zhu L., Jin Y., Ji H., Yan X., Zhu X. miR-375 is highly expressed and possibly transactivated by achaete-scute complex homolog 1 in small-cell lung cancer cells. Acta Biochim Biophys Sin (Shanghai) 2012, 44(February (2)):177-182.
    • (2012) Acta Biochim Biophys Sin (Shanghai) , vol.44 , Issue.2 FEBRUARY , pp. 177-182
    • Zhao, H.1    Zhu, L.2    Jin, Y.3    Ji, H.4    Yan, X.5    Zhu, X.6
  • 36
    • 84455163058 scopus 로고    scopus 로고
    • Tumor suppressive microRNA-375 regulates lactate dehydrogenase B in maxillary sinus squamous cell carcinoma
    • Kinoshita T., Nohata N., Yoshino H., Hanazawa T., Kikkawa N., Fujimura L., et al. Tumor suppressive microRNA-375 regulates lactate dehydrogenase B in maxillary sinus squamous cell carcinoma. Int J Oncol 2012, 40(January (1)):185-193.
    • (2012) Int J Oncol , vol.40 , Issue.1 JANUARY , pp. 185-193
    • Kinoshita, T.1    Nohata, N.2    Yoshino, H.3    Hanazawa, T.4    Kikkawa, N.5    Fujimura, L.6
  • 37
    • 84055212101 scopus 로고    scopus 로고
    • Significance of dysregulated metadherin and microRNA-375 in head and neck cancer
    • Hui A.B., Bruce J.P., Alajez N.M., Shi W., Yue S., Perez-Ordonez B., et al. Significance of dysregulated metadherin and microRNA-375 in head and neck cancer. Clin Cancer Res 2011, 17(December (24)):7539-7550.
    • (2011) Clin Cancer Res , vol.17 , Issue.24 DECEMBER , pp. 7539-7550
    • Hui, A.B.1    Bruce, J.P.2    Alajez, N.M.3    Shi, W.4    Yue, S.5    Perez-Ordonez, B.6
  • 38
    • 84863141727 scopus 로고    scopus 로고
    • Low-level expression of miR-375 correlates with poor outcome and metastasis while altering the invasive properties of head and neck squamous cell carcinomas
    • Harris T., Jimenez L., Kawachi N., Fan J.B., Chen J., Belbin T., et al. Low-level expression of miR-375 correlates with poor outcome and metastasis while altering the invasive properties of head and neck squamous cell carcinomas. Am J Pathol 2012, 180(March (3)):917-928.
    • (2012) Am J Pathol , vol.180 , Issue.3 MARCH , pp. 917-928
    • Harris, T.1    Jimenez, L.2    Kawachi, N.3    Fan, J.B.4    Chen, J.5    Belbin, T.6
  • 39
    • 83555177355 scopus 로고    scopus 로고
    • MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor
    • Kong K.L., Kwong D.L., Chan T.H., Law S.Y., Chen L., Li Y., et al. MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor. Gut 2012, 61(January (1)):33-42.
    • (2012) Gut , vol.61 , Issue.1 JANUARY , pp. 33-42
    • Kong, K.L.1    Kwong, D.L.2    Chan, T.H.3    Law, S.Y.4    Chen, L.5    Li, Y.6
  • 40
    • 79959251756 scopus 로고    scopus 로고
    • Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection
    • Zhang X., Yan Z., Zhang J., Gong L., Li W., Cui J., et al. Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection. Ann Oncol 2011, 22(October (10)):2257-2266.
    • (2011) Ann Oncol , vol.22 , Issue.10 OCTOBER , pp. 2257-2266
    • Zhang, X.1    Yan, Z.2    Zhang, J.3    Gong, L.4    Li, W.5    Cui, J.6
  • 41
    • 66849140943 scopus 로고    scopus 로고
    • MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents
    • Cochrane D.R., Spoelstra N.S., Howe E.N., Nordeen S.K., Richer J.K. MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents. Mol Cancer Ther 2009, 8(May (5)):1055-1066.
    • (2009) Mol Cancer Ther , vol.8 , Issue.5 MAY , pp. 1055-1066
    • Cochrane, D.R.1    Spoelstra, N.S.2    Howe, E.N.3    Nordeen, S.K.4    Richer, J.K.5
  • 42
    • 84860261087 scopus 로고    scopus 로고
    • High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer
    • Liu X.G., Zhu W.Y., Huang Y.Y., Ma L.N., Zhou S.Q., Wang Y.K., et al. High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer. Med Oncol 2012, 29(June (2)):618-626.
    • (2012) Med Oncol , vol.29 , Issue.2 JUNE , pp. 618-626
    • Liu, X.G.1    Zhu, W.Y.2    Huang, Y.Y.3    Ma, L.N.4    Zhou, S.Q.5    Wang, Y.K.6
  • 43
    • 84863012463 scopus 로고    scopus 로고
    • Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors
    • Xu Y., Brenn T., Brown E.R., Doherty V., Melton D.W. Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors. Br J Cancer 2012, 106(January (3)):553-561.
    • (2012) Br J Cancer , vol.106 , Issue.3 JANUARY , pp. 553-561
    • Xu, Y.1    Brenn, T.2    Brown, E.R.3    Doherty, V.4    Melton, D.W.5
  • 44
    • 79960037044 scopus 로고    scopus 로고
    • MiR-29c induces cell cycle arrest in esophageal squamous cell carcinoma by modulating cyclin E expression
    • Ding D.P., Chen Z.L., Zhao X.H., Wang J.W., Sun J., Wang Z., et al. miR-29c induces cell cycle arrest in esophageal squamous cell carcinoma by modulating cyclin E expression. Carcinogenesis 2011, 32(July (7)):1025-1032.
    • (2011) Carcinogenesis , vol.32 , Issue.7 JULY , pp. 1025-1032
    • Ding, D.P.1    Chen, Z.L.2    Zhao, X.H.3    Wang, J.W.4    Sun, J.5    Wang, Z.6
  • 45
    • 84855191863 scopus 로고    scopus 로고
    • The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2
    • Zheng F., Liao Y.J., Cai M.Y., Liu Y.H., Liu T.H., Chen S.P., et al. The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut 2012, 61(February (2)):278-289.
    • (2012) Gut , vol.61 , Issue.2 FEBRUARY , pp. 278-289
    • Zheng, F.1    Liao, Y.J.2    Cai, M.Y.3    Liu, Y.H.4    Liu, T.H.5    Chen, S.P.6
  • 46
    • 78650779471 scopus 로고    scopus 로고
    • Down-regulation of mir-424 contributes to the abnormal angiogenesis via MEK1 and cyclin E1 in senile hemangioma: its implications to therapy
    • Nakashima T., Jinnin M., Etoh T., Fukushima S., Masuguchi S., Maruo K., et al. Down-regulation of mir-424 contributes to the abnormal angiogenesis via MEK1 and cyclin E1 in senile hemangioma: its implications to therapy. PLoS One 2010, 5(12):e14334.
    • (2010) PLoS One , vol.5 , Issue.12
    • Nakashima, T.1    Jinnin, M.2    Etoh, T.3    Fukushima, S.4    Masuguchi, S.5    Maruo, K.6
  • 47
    • 79952195451 scopus 로고    scopus 로고
    • Expression and function of miRNA in postoperative radiotherapy sensitive and resistant patients of non-small cell lung cancer
    • Wang X.C., Du L.Q., Tian L.L., Wu H.L., Jiang X.Y., Zhang H., et al. Expression and function of miRNA in postoperative radiotherapy sensitive and resistant patients of non-small cell lung cancer. Lung Cancer 2011, 72(April (1)):92-99.
    • (2011) Lung Cancer , vol.72 , Issue.1 APRIL , pp. 92-99
    • Wang, X.C.1    Du, L.Q.2    Tian, L.L.3    Wu, H.L.4    Jiang, X.Y.5    Zhang, H.6
  • 48
    • 59649093464 scopus 로고    scopus 로고
    • Evolution of microRNA expression during human bronchial squamous carcinogenesis
    • Mascaux C., Laes J.F., Anthoine G., Haller A., Ninane V., Burny A., et al. Evolution of microRNA expression during human bronchial squamous carcinogenesis. Eur Respir J 2009, 33(February (2)):352-359.
    • (2009) Eur Respir J , vol.33 , Issue.2 FEBRUARY , pp. 352-359
    • Mascaux, C.1    Laes, J.F.2    Anthoine, G.3    Haller, A.4    Ninane, V.5    Burny, A.6
  • 49
    • 84878975723 scopus 로고    scopus 로고
    • Does histology predict survival of advanced non-small cell lung cancer patients treated with platin-based chemotherapy? An analysis of the Eastern Cooperative Oncology Group Study E1594
    • Hoang T., Dahlberg S.E., Schiller J.H., Johnson D.H. Does histology predict survival of advanced non-small cell lung cancer patients treated with platin-based chemotherapy? An analysis of the Eastern Cooperative Oncology Group Study E1594. Lung Cancer 2013, 81(July (1)):47-52.
    • (2013) Lung Cancer , vol.81 , Issue.1 JULY , pp. 47-52
    • Hoang, T.1    Dahlberg, S.E.2    Schiller, J.H.3    Johnson, D.H.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.